Recommended Pages at ivdtechnology.com
PerkinElmer, TPM Biotech to Validate Detection Kits for Food Screening | IVD Technology
ivdtechnology.com — “PerkinElmer Inc. has entered into an agreement with TPM Biotech SDN. BHD. (TPMB), a Malaysian laboratory for Halal food testing services, to explore potential applications of PerkinElmer's Porcine Detection Kits and chromatography solutions for use in validating methods of testing food products for compliance with Halal certification regulations.” View full resource at ivdtechnology.com
Most Recently Shared on April 10, 2012 at 5:49 pm By:
IVD Technology Health Magazine
PerkinElmer, TPM Biotech to Validate Detection Kits for Food Screening http://t.co/lfgasPBA
GenMark + Advanced Liquid Logic to Develop All-Electronic, Fully Integrated Dx Platform | IVD Technology
ivdtechnology.com — “GenMark Diagnostics Inc. and Advanced Liquid Logic Inc. are collaborating to develop an all-electronic, fully integrated IVD platform combining Advanced Liquid Logic’s proprietary electrowetting technology and GenMark’s proprietary electrochemical detection. GenMark is a provider of automated, multiplex molecular-dx testing systems that detect and measure DNA and RNA targets to diagnose disease and personalize patient treatment.” View full resource at ivdtechnology.com
Most Recently Shared on April 9, 2012 at 5:30 pm By:
IVD Technology Health Magazine
GenMark + Advanced Liquid Logic to Develop All-Electronic, Fully Integrated Dx Platform http://t.co/wpKVUgKY
IntegraGen Launches Genetic Screening Tool for Autism | IVD Technology
ivdtechnology.com — “IntegraGen Inc., a biotechnology company that bills itself as being "dedicated to molecular biomarker discovery," announced the launch of the ARISk risk assessment test for genetically screening for autism spectrum disorder (ASD). The test is gender-specific and looks at 65 genetic markers associated with ASD. It is designed to assess the risk of autism in children from multiplex families—siblings of children with ASD who are 6 to 30 months of age.” View full resource at ivdtechnology.com
Most Recently Shared on April 6, 2012 at 7:37 pm By:
IVD Technology Health Magazine
IntegraGen Launches Genetic Screening Tool for Autism http://t.co/ty8vAQrG
Proteome Sciences Licenses Stroke Biomarkers to Randox | IVD Technology
ivdtechnology.com — “Proteome Sciences plc Randox Laboratories for its portfolio of stroke biomarkers. Proteome Sciences has established a portfolio of patented plasma biomarkers of stroke and other brain damage-related disorders discovered in partnership with the Biomedical Proteomics Research Group (BPRG) at the University of Geneva.” View full resource at ivdtechnology.com
Most Recently Shared on April 5, 2012 at 5:17 pm By:
IVD Technology Health Magazine
Proteome Sciences Licenses Stroke Biomarkers to Randox http://t.co/oPLL6Y0D
Developing a Separation Matrix for Measuring Percent HbA1c | IVD Technology
ivdtechnology.com — “Developing a separation matrix for measuring percent HbA1c Hemoglobin A1c (HbA1c) is uniquely suited for diagnosing diabetes and monitoring its treatment with a specific number of tests per year (typically on a quarterly basis). Recent initiatives by the United Nations, the World Health Organization, and the International Diabetes Federation (IDF) have addressed the worldwide diabetes epidemic and the need for better diagnosis and treatment.” View full resource at ivdtechnology.com
Most Recently Shared on April 5, 2012 at 12:00 am By:
IVD Technology Health Magazine
Developing a Separation Matrix for Measuring Percent HbA1c http://t.co/0erPIPTO
GE Healthcare Acquires SeqWright | IVD Technology
ivdtechnology.com — “GE Healthcare has acquired SeqWright Inc., a provider of nucleic acid sequencing and other genomic services. The acquisition adds complementary genomics capabilities to Clarient, a unit of GE Healthcar. The deal also provides a platform for Clarient to expand its clinical diagnostic offerings to include next generation sequencing. Financial terms of the acquisition were not disclosed.” View full resource at ivdtechnology.com
Most Recently Shared on April 4, 2012 at 5:37 pm By:
IVD Technology Health Magazine
GE Healthcare Acquires SeqWright http://t.co/tBQmHWN1
OPKO Health Announces License Agreement for Alzheimer’s IVD | IVD Technology
ivdtechnology.com — “OPKO Health Inc. has signed an agreement with Laboratory Corporation of America Holdings (LabCorp) under which LabCorp licensed exclusive rights in North America and the United Arab Emirates to OPKO’s intellectual property to develop and commercialize laboratory testing services for Alzheimer’s disease. Financial terms of the transaction were not disclosed.” View full resource at ivdtechnology.com
Most Recently Shared on April 3, 2012 at 3:36 pm By:
IVD Technology Health Magazine
OPKO Health Announces License Agreement for Alzheimer’s IVD http://t.co/YElizmyC
Good Start Genetics Secures $14M Financing | IVD Technology
ivdtechnology.com — “Good Start Genetics completed the initial closing of a $14 million Series B Preferred Stock financing, which was led by existing investors OrbiMed Advisors, Safeguard Scientifics Inc., and SV Life Sciences. Proceeds from this financing will be used to augment commercial efforts for the Company’s pre-conception carrier screening tests, and to support continued R&D efforts around its proprietary technology platform for future applications.” View full resource at ivdtechnology.com
Most Recently Shared on April 2, 2012 at 6:54 pm By:
IVD Technology Health Magazine
Good Start Genetics Secures $14M Financing http://t.co/WDRJ8ryy
Asuragen Gains $6.8M Award on Next-Generation Sequencing | IVD Technology
ivdtechnology.com — “Asuragen Inc. received notice of a $6.8 million commercialization award to pursue next-generation sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas (CPRIT). “NGS has generated excitement in life sciences and healthcare by facilitating the rapid and cost effective determination of large volumes of sequence information.” View full resource at ivdtechnology.com
Most Recently Shared on April 2, 2012 at 5:40 pm By:
IVD Technology Health Magazine
Asuragen Gains $6.8M Award on Next-Generation Sequencing http://t.co/XFbsqpO9
IschemiaCare Partners With Medtronic and Affymetrix on Stroke Dx | IVD Technology
ivdtechnology.com — “Start-up company IschemiaCare is developing a blood test to diagnose the cause of stroke and is planning a clinical study that could lead to commercial sales of the test, reported MedCityNews this week. The Cincinnati-based company plans to begin the study in the second half of this year, MedCityNews says, and it has enlisted Medtronic and genetic-analysis company Affymetrix to help.” View full resource at ivdtechnology.com
Most Recently Shared on March 30, 2012 at 6:44 pm By:
IVD Technology Health Magazine
IschemiaCare Partners With Medtronic and Affymetrix on Stroke Dx http://t.co/td83ruXE
Avioq Receives FDA Approval for HTLV-I/II Test | IVD Technology
ivdtechnology.com — “Avioq Inc. has received approval from FDA for the Avioq HTLV-I/II Microelisa System. The test is used for the qualitative detection of antibodies to Human T-Lymphotropic Virus Type I (HTLV-I) and Human T-Lymphotropic Virus Type II (HTLV-II) in human serum or plasma.” View full resource at ivdtechnology.com
Most Recently Shared on March 29, 2012 at 4:42 pm By:
IVD Technology Health Magazine
Avioq Receives FDA Approval for HTLV-I/II Test http://t.co/OUZOvWq1
Bill proposes modernizing IVD regulations | IVD Technology
ivdtechnology.com — “Congressman Leonard Lance (R-NJ) introduced legislation to promote the development of meaningful treatments for patients with chronic or rare diseases. The “Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network (MODDERN) Cures Act” (HR 3497) would modernize the U.S. drug and diagnostics evaluation and regulatory network by encouraging the discovery and development of new treatments for the many diseases that have few or no options.” View full resource at ivdtechnology.com
Most Recently Shared on March 28, 2012 at 9:09 pm By:
IVD Technology Health Magazine
Bill proposes modernizing IVD regulations http://t.co/hIN3ax1o
BD GBS Assay Receives FDA Clearance, CLIA Moderate Complexity Test Categorization | IVD Technology
ivdtechnology.com — “BD (Becton, Dickinson and Company) announced FDA clearance of the BD MAX Group B Streptococcus (GBS) Assay and Clinical Laboratory Improvement Amendments (CLIA) moderate complexity test categorization on the second-generation BD MAX System. The BD MAX GBS Assay is an IVD test for the detection of GBS DNA in Lim Broth cultures, enabling laboratories to comply with the 2010 CDC guidelines for GBS screening.” View full resource at ivdtechnology.com
Most Recently Shared on March 28, 2012 at 5:09 pm By:
IVD Technology Health Magazine
BD GBS Assay Receives FDA Clearance, CLIA Moderate Complexity Test Categorization http://t.co/rekNPxGo
Bristol-Myers Squibb, Meso Scale Discovery to Develop Assays for Alzheimer’s Disease | IVD Technology
ivdtechnology.com — “Bristol-Myers Squibb Company and Meso Scale Discovery have entered an agreement to develop diagnostic assays that will measure cerebrospinal fluid biomarkers for use in Alzheimer’s disease research. Under the terms of the agreement, the companies will develop these assays based on the Meso Scale Discovery MULTI-ARRAY technology platform.” View full resource at ivdtechnology.com
Most Recently Shared on March 28, 2012 at 5:02 pm By:
IVD Technology Health Magazine
Bristol-Myers Squibb, Meso Scale Discovery to Develop Assays for Alzheimer’s Disease http://t.co/OIxsIC8b
DiaGenic, GE Healthcare to Develop Test for Mild Cognitive Impairment | IVD Technology
ivdtechnology.com — “DiaGenic ASA announced a research agreement to collaborate with GE Healthcare to develop a blood-based test using DiaGenic’s peripheral gene expression profiling in patients with mild cognitive impairment, a disorder associated with risk for Alzheimer’s Disease. The study would be used in conjunction with PET imaging to identify a blood based gene expression signature in these patients.” View full resource at ivdtechnology.com
Most Recently Shared on March 26, 2012 at 5:38 pm By:
IVD Technology Health Magazine
DiaGenic, GE Healthcare to Develop Test for Mild Cognitive Impairment http://t.co/gbD0qxrT
